Why Smiths Group's medical sale got the thumbs up from investors
FTSE 100 constituent Smiths Group (SMIN) gained 4.1% to £14.19 on a positive set of full year results and confirmation it is offloading its medical arm.Essentially a conglomerate business with an engineering focus, Smiths had long...
28 September 2021